How Long Does Cyclobenzaprine Stay in Your System?

Cyclobenzaprine, the muscle relaxant sold under the brand name Flexeril among others, has an effective half-life of about 18 hours in healthy adults, which means the drug takes roughly four to five days to clear from your body after your last dose. That number can stretch considerably longer depending on your age, liver health, and what other medications you take. The gap between when cyclobenzaprine stops relieving your muscle spasm and when it actually leaves your bloodstream is surprisingly wide, and that distinction matters for drug testing, side effects, and interactions.

The Half-Life That Drives Everything

In pharmacokinetic studies of healthy young adults taking standard doses three times daily, cyclobenzaprine showed an effective half-life of 18 hours, with drug levels in the blood roughly quadrupling over the course of multiple days of dosing before reaching a steady state.¹ That 18-hour figure is the one most commonly cited by clinicians, and it is useful for estimating how long the drug stays active in your blood at meaningful levels.

However, more detailed pharmacokinetic modeling reveals a multi-compartment picture. Cyclobenzaprine leaves the body in phases: an initial rapid phase with a half-life of about 3 hours, followed by a much slower terminal elimination phase with a half-life averaging around 32 hours.² The practical difference is that after you stop taking cyclobenzaprine, most of it drops out of your blood relatively fast, but a residual amount lingers at very low concentrations for considerably longer. Using the standard pharmacology rule that it takes about five half-lives for a drug to fall below detectable levels, the 18-hour effective half-life points to clearance in roughly four days, while the 32-hour terminal half-life suggests trace amounts could persist for a week or more in some people.

When the Muscle Relaxation Stops vs. When the Drug Actually Leaves

One of the most confusing things about cyclobenzaprine is that its pain-relieving and muscle-relaxing effects wear off much sooner than the drug disappears from your body. The clinical duration of action is only about four to six hours per dose.³ That is why the immediate-release version is prescribed two to three times a day rather than once: if you only took it in the morning, the muscle-relaxing benefit would fade well before bedtime.

Yet the drug itself stays in your bloodstream for days after you stop. This means that while you may no longer feel any therapeutic benefit, your liver is still processing cyclobenzaprine, and side effects like drowsiness, dry mouth, or dizziness can linger beyond the point where the drug is doing anything useful for your muscles. It also means the drug can still interact with other medications you might start taking, even after it has stopped “working” from your perspective.

Immediate-Release vs. Extended-Release Formulations

Cyclobenzaprine comes in two main formulations, and they behave differently in terms of how quickly the drug enters your blood, though they deliver similar total exposure over 24 hours. The immediate-release tablet reaches its first peak concentration in about four hours, then drops and spikes again with each subsequent dose, creating a pattern of peaks and troughs throughout the day. The extended-release capsule smooths that out into a single, more gradual rise, reaching its peak at roughly six hours and maintaining steadier levels.⁴

Despite the different absorption patterns, total drug exposure is similar between the two formulations, which means the overall time it takes your body to clear the drug does not change dramatically based on which version you take. The extended-release capsule is dosed once daily precisely because the drug’s long half-life allows a single dose to maintain adequate blood levels throughout the day. The elimination timeline after your last dose is largely determined by the same half-life either way.

How Your Liver Processes Cyclobenzaprine

Cyclobenzaprine is broken down almost entirely in the liver, primarily by two enzyme systems known as CYP3A4 and CYP1A2. A third enzyme, CYP2D6, plays a minor supporting role.⁵ The main metabolite produced is called norcyclobenzaprine (desmethylcyclobenzaprine), and the drug and its metabolites are eventually excreted through the kidneys.

This liver-dependent metabolism is the reason why the clearance timeline varies so much between individuals. CYP3A4 and CYP1A2 are influenced by genetics, diet, smoking status, and other medications. Smokers, for instance, tend to have more active CYP1A2 enzymes, which could speed up metabolism. Conversely, people taking medications that inhibit CYP3A4, a very common enzyme pathway shared by dozens of drugs, could find cyclobenzaprine lingering in their system longer than expected.

Factors That Slow Clearance

Several real-world variables can push cyclobenzaprine’s stay in your system well beyond the average timelines.

• Liver impairment: Because cyclobenzaprine depends so heavily on liver metabolism, any degree of liver disease or reduced liver function slows clearance. The pharmacokinetic studies that established the 18-hour effective half-life specifically noted that hepatic insufficiency alters the drug’s elimination.¹ For people with moderate to severe liver disease, the drug can take substantially longer to clear, and dosing adjustments are generally recommended.
• Age: Older adults process the drug more slowly. Pharmacokinetic studies have specifically compared the drug’s behavior in elderly volunteers versus younger adults, measuring differences in peak concentration, total exposure, and elimination time.⁶ Reduced liver blood flow and less efficient enzyme activity in older adults contribute to longer clearance times.
• Drug interactions: Medications that compete for the same liver enzymes can alter how fast or slow cyclobenzaprine is metabolized. One study examining a combination hepatitis C treatment regimen found that co-administration reduced cyclobenzaprine exposure by up to 40%, suggesting the interaction sped up its metabolism.⁷ The reverse can also happen: drugs that inhibit CYP3A4 or CYP1A2, such as certain antibiotics, antifungals, and grapefruit juice, can slow cyclobenzaprine metabolism and effectively extend the drug’s stay in your body.
• Dose and duration of use: Because cyclobenzaprine accumulates to about four times its single-dose levels during regular three-times-daily dosing, someone who has been taking it for several weeks will have more drug built up in their tissues than someone who took a single pill. That larger reservoir takes proportionally longer to clear.¹

Drug Testing and Cyclobenzaprine

Cyclobenzaprine is not a controlled substance in most jurisdictions and is not part of the standard drug panels used in employment or athletic testing, which typically screen for substances like amphetamines, opioids, cannabis, cocaine, and benzodiazepines. However, the drug has a structural backbone closely resembling tricyclic antidepressants, and this chemical similarity can cause it to trigger a false positive on immunoassay-based urine screens for tricyclic antidepressants. If you are facing a drug test and take cyclobenzaprine, this is worth mentioning to the testing facility in advance.

Laboratories can detect cyclobenzaprine directly in both blood and urine using more specific analytical methods. Validated assay techniques can identify the drug in urine at concentrations from 10 to 1,000 ng/mL and in plasma at concentrations as low as 0.1 ng/mL.⁸ Because the terminal elimination half-life is about 32 hours, extremely sensitive tests could pick up trace amounts of the drug in urine for well over a week after your last dose, particularly if you had been taking it regularly. For most practical purposes, though, the drug falls below clinically relevant levels within about four to five days for a person with normal liver function.

If a confirmatory test is run using mass spectrometry or a similar technique, cyclobenzaprine can be specifically identified and distinguished from actual tricyclic antidepressants. The false-positive concern applies only to the initial immunoassay screening step, not to the confirmation.

Side Effects That Outlast the Therapeutic Window

Because cyclobenzaprine stays in your body long after its muscle-relaxing effects fade, certain side effects can persist during the tail end of elimination. Drowsiness and sedation are the most common complaints and can be meaningful the morning after a bedtime dose, particularly in older adults or anyone whose metabolism is slower than average. Dry mouth, another frequent side effect, follows a similar pattern.

In rare cases, cyclobenzaprine has been associated with more serious neuropsychiatric reactions. A published case report described a patient who developed delirium and abnormal involuntary movements shortly after starting cyclobenzaprine alongside an opioid. Those symptoms resolved within 48 hours of stopping the cyclobenzaprine.⁹ The 48-hour resolution timeline aligns with what the pharmacokinetics predict: by two half-lives after the last dose, most of the drug has been eliminated, and side effects tied to its central nervous system activity should begin fading. Severe reactions like this one are uncommon, but the fact that they cleared within two days provides a useful real-world anchor for how quickly the drug’s active effects dissipate even when the drug itself has not fully left the body.

Cyclobenzaprine and Breastfeeding

For nursing parents, the question of how long cyclobenzaprine stays in the system extends to whether the drug reaches the infant through breast milk. A dedicated pharmacokinetic study measured cyclobenzaprine concentrations in human milk and found very low levels, with a calculated relative infant dose of about 0.5%.¹⁰ In pharmacology terms, a relative infant dose below 10% is generally considered compatible with breastfeeding for most medications, so the 0.5% figure is reassuringly low.

That said, cyclobenzaprine is a sedating drug, and infants metabolize drugs more slowly than adults. The study’s authors recommended regular clinical assessment of the nursing infant for sedation or other effects. If you are breastfeeding and have been prescribed cyclobenzaprine for a short course, the drug’s low milk transfer is good news, but its long half-life means it will be present in your milk for several days after your last dose, not just a few hours. Timing around feedings is less useful than it might be for a short-acting drug precisely because the elimination is so slow.

Why Cyclobenzaprine Is Typically Limited to Short Courses

Most prescribing guidelines recommend using cyclobenzaprine for no more than two to three weeks. Part of the reason is that the evidence for muscle relaxant benefit in chronic use is thin, but the pharmacokinetics also play a role. With an 18-hour effective half-life and fourfold accumulation during regular dosing, the drug builds up considerably in your tissues over time.¹ That buildup means side effects like drowsiness and anticholinergic symptoms (dry mouth, constipation, urinary retention, blurred vision) can become more pronounced with continued use, especially in people who clear the drug slowly.

The drug’s structural similarity to tricyclic antidepressants is not just a drug-testing curiosity. It means cyclobenzaprine shares some of the same pharmacological baggage: anticholinergic activity, potential cardiac effects at high doses, and additive sedation when combined with alcohol or other central nervous system depressants. These properties become more concerning the longer the drug is used and the more it accumulates. For someone who has been taking cyclobenzaprine daily for two or three weeks, the washout period after stopping may be noticeably longer than for someone who took it for two or three days, simply because there is more drug stored in the body’s tissues waiting to be metabolized.

Putting the Timeline Together

For a single dose in a healthy young adult, the muscle-relaxing effects last about four to six hours, while the drug itself drops to half its peak level in roughly 18 hours and reaches negligible blood concentrations within three to four days. For someone who has been taking it regularly, the accumulated drug takes longer to fully clear, and five to seven days is a reasonable estimate for the drug to fall below levels detectable by standard laboratory methods, using the 32-hour terminal half-life as a guide.² For older adults, people with liver disease, or those taking interacting medications, add extra time. In the most extreme cases, traces could linger for 10 days or more.

If you are stopping cyclobenzaprine before a medical procedure, before starting a new medication that might interact, or in anticipation of a drug test, a conservative approach is to allow at least a full week after your last dose. For most people in good health who took a short course, four to five days is likely sufficient for the drug to fall below any clinically meaningful threshold. Your prescriber can help you judge where in that range you fall based on your specific health profile and medication list.